Morgan Stanley Put 75 RVTY 20.09..../ DE000ME2W498 /
| 2024-05-02 9:14:39 AM | Chg.-0.012 | Bid9:31:46 AM | Ask9:31:46 AM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 0.127EUR | -8.63% | 0.126 Bid Size: 2,000 |
0.175 Ask Size: 2,000 |
Revvity Inc | 75.00 USD | 2024-09-20 | Put |
GlobeNewswire
01-19
Bionano Announces the Final Speaker Lineup for 2024 Symposium with 33 OGM Presentations and Live Pan...
GlobeNewswire
01-08
Pleno Deploys its RAPTOR Instrument Platform Available with TotalSeq™ Antibodies from BioLegend
GlobeNewswire
2023-11-30
Study Shows that OGM Plays an Important Role in Efficient Diagnosis of FSHD
GlobeNewswire
2023-11-13
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Revvity, Inc. -...
GlobeNewswire
2023-11-05
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Revvity, Inc. - ...
GlobeNewswire
2021-05-18
Oxford Immunotec’s T-SPOT Discovery SARS-CoV-2 Test is Used in the UK COVID-19 Human Challenge Study...
GlobeNewswire
2021-05-11
Oxford Immunotec’s T-SPOT.COVID Test is Used in the COV-AD Clinical Study to Investigate the Immunol...
GlobeNewswire
2021-04-29
Oxford Immunotec’s T-SPOT Discovery SARS-CoV-2 Test Used in DIRECT Study to Investigate the T Cell R...
